Medera’s SPAC Merger Marks Rare Biotech Move
Medera aims for Nasdaq listing via SPAC to boost gene therapies, spotlighting rare biotech SPACs in 2024.
- Latest
- Trending
Medera aims for Nasdaq listing via SPAC to boost gene therapies, spotlighting rare biotech SPACs in 2024.
Alloy reveals revenue potential of embedded finance, yet compliance hurdles remain a concern for sponsor banks.
MITRE's new initiative, Defending OT with ATT&CK, strengthens security for critical infrastructure by detailing adversarial techniques.
MSCI's index adjustment could lead to $2.5 billion inflows into HDFC Bank, thanks to an increase in foreign inclusion factors.
Roundhill Ball Metaverse ETF adds 6.8% ether and 2.0% bitcoin via CI Galaxy ETFs, highlighting the critical role of crypto ...
The Shiba Inu (SHIB) community is showing interest in Option2Trade (O2T), a new DeFi AI token gaining popularity in the ...
Discover how the role of safety technology is evolving in workplace management, including the importance of reliable and adaptable solutions.
Planning and integrating recovery into the security stack is crucial in dealing with breaches. It's important to prioritize security over ...
Is it safe to buy stocks with the S&P 500 near its record high? Berkshire was a net seller of ...
Uncover the next 24-hour trajectory of Dogecoin with a detailed financial analysis predicting price movements based on historical data, market ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.